Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
calcium acetate 2 nephrologydiseasesdrugs
chronic kidney disease 2 nephrologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.


Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
calcium acetate 6351 assigned to a 12-month treatment of either magnesium-containing phosphate binders (magnesium carbonate/ calcium acetate ) or calcium-containing phosphate binders (calcium acetate) [[30]]. The two groups were then compared
calcium acetate 6409 magnesium-containing phosphate binders (magnesium carbonate/calcium acetate) or calcium-containing phosphate binders ( calcium acetate ) [[30]]. The two groups were then compared with respect to the progression of arterial calcification.
Select Disease Character Offset Disease Term Instance
chronic kidney disease 1028 endothelial function. The relationship between magnesium and cardiovascular prognosis among patients with chronic kidney disease (CKD) has been increasingly investigated as it is becoming evident that magnesium can inhibit vascular
chronic kidney disease 3130 mineral for the cardiovascular system, this divalent cation has received little attention in the field of chronic kidney disease (CKD). However, the low magnesium status may also be unfavorable for CKD patients since it is associated

You must be authorized to submit a review.